BIOLASE, Inc. (BIOL)
Pre-market:
- Insider Monkey
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript March 21, 2024 BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.56. BIOL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the BIOLASE Fourth […]
- PR Newswire
BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced preliminary unaudited revenue results for 2023 based on currently available information and expects to report year-over-year growth as it continues to generate interest among dental practitioners for its industry leading lasers. The Company is also taking additional steps to optimize operations and believes its revenue-generating strategies and prudent management of its expenses will enable it to achieve its sales and pr
